CAR T cell therapy: A systemic analysis of its potential to reset the immune system and address autoimmune disease
Original framing: “A revolutionary cancer treatment could transform autoimmune disease” — Ars Technica
The history of autoimmune disease treatment is marked by colonialism and racism, which have shaped healthcare disparities and limited access to effective treatment. The development of CAR T cell therapy must be understood within this broader historical context, recognizing the power dynamics that have influenced healthcare policy and practice. By acknowledging these historical patterns, we can work towards more equitable and effective treatment strategies.
The development of CAR T cell therapy must be understood within the broader context of autoimmune disease treatment, which is shaped by historical patterns of colonialism and racism.
By centering the knowledge and perspectives of marginalized communities, we can develop more holistic and equitable approaches to treatment. This requires a commitment to decolonizing healthcare, recognizing the value of traditional knowledge and practices, and addressing the structural causes of immune system dysregulation. By working towards more equitable healthcare systems and promoting greater health equity, we can reduce disparities in autoimmune disease treatment and promote greater well-being and resilience for individuals and communities affected by this condition.